From: Richard Kahn < Sent: Tuesday, April 7, 2015 2:38 PM To: jeffrey E. Subject: Foundation Medicine and Roche Complete Strategic Transaction to Advance Molecular Information and Precision Medicine in Oncology http://investors.foundationmedicine.com/releasedetail.dm?ReleaselD=905240 Richard Kahn HBRK Associates Inc. New York, NY 10022 tel fax cell 1 EFTA_R1_00040342 EFTA01746557